{"id":5762,"date":"2022-10-21T13:18:23","date_gmt":"2022-10-21T11:18:23","guid":{"rendered":"https:\/\/labradoodle.pl\/?page_id=5762"},"modified":"2022-11-29T09:32:20","modified_gmt":"2022-11-29T08:32:20","slug":"testy-zdrowotne","status":"publish","type":"page","link":"https:\/\/labradoodle.pl\/de\/testy-zdrowotne\/","title":{"rendered":"Gesundheitstests"},"content":{"rendered":"

[et_pb_section fb_built=\u201c1\u2033 admin_label=\u201csection\u201c _builder_version=\u201c4.16\u2033 global_colors_info=\u201c{}\u201c][et_pb_row admin_label=\u201crow\u201c _builder_version=\u201c4.16\u2033background_size=\u201cinitial\u201cbackground_position=\u201ctop_left\u201cbackground_repeat=\u201crepeat \u201d global_colors_info=\u201c{}\u201c][et_pb_column type=\u201c4_4\u2033 _builder_version=\u201c4.16\u2033 custom_padding=\u201c|||\u201c global_colors_info=\u201c{}\u201c custom_padding__hover=\u201c|||\u201c][et_pb_text _builder_version=\u201c4.18.0\u201c _module_preset=\u201cdefault\u201c global_colors_info=\u201c{}\u201c]<\/p>\n

Gesundheitstests<\/h1>\n

[\/et_pb_text][et_pb_text admin_label=\u201cText\u201c _builder_version=\u201c4.18.0\u2033 text_font=\u201c|300|||||||\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c global_colors_info=\u201c{}\u201c]<\/p>\n

Australischer Labradoodle und Gesundheitstests. Auf folgende Krankheiten testen wir unsere Hunde:<\/h4>\n
<\/div>\n
Haupts\u00e4chlich:<\/strong><\/strong><\/div>\n
<\/strong><\/div>\n
\u2013 H\u00fcft- und Ellenbogendysplasie (FCI-Standards)<\/div>\n
\u2013 Falsches Fell<\/div>\n
\u2013 Von-Willebrand-Krankheit Typ I, Typ I vWD (VWF)
\u2013 Elliptozytose des Hundes (SPTB Exon 30)
\u2013 Pyruvatkinase-Mangel (PKLR Exon 7, Labrador-Retriever-Variante)
\u2013 Progressive Netzhautatrophie, prcd (PRCD Exon 1)
\u2013 Golden Retriever Progressive Netzhautatrophie 2, GR-PRA2 (TTC8)
\u2013 Progressive Netzhautatrophie, crd4\/cord1 (RPGRIP1)
\u2013 Achromatopsie (CNGA3 Exon 7, Labrador-Retriever-Variante)
\u2013 Makula-Hornhaut-Dystrophie, MCD (CHST6)
\u2013 Hyperurikosurie und Hyperurik\u00e4mie oder Urolithiasis, HUU (SLC2A9)
\u2013 Angeborene Keratokonjunktivitis Sicca und Ichthyosiforme Dermatose, trockenes, lockiges Fell am Auge
\u2013 Syndrom, CKCSID (FAM83H Exon 5)
\u2013 GM2-Gangliosidose (HEXB, Pudelvariante)
\u2013 Alexander-Krankheit (GFAP)
\u2013 Degenerative Myelopathie, DM (SOD1A)
\u2013 Neonatale Enzephalopathie mit Anf\u00e4llen, NEWS (ATF2)
\u2013 Narkolepsie (HCRTR2 Intron 6, Labrador-Retriever-Variante)
\u2013 Muskeldystrophie (DMD, Cavalier King Charles Spaniel Variante 1)
\u2013 Ullrich-\u00e4hnliche angeborene Muskeldystrophie (COL6A3 Exon 10, Labrador-Retriever-Variante)
\u2013 Zentronukle\u00e4re Myopathie, CNM (PTPLA)
\u2013 Belastungsinduzierter Kollaps, EIC (DNM1)
\u2013 Myotubul\u00e4re Myopathie 1, X-chromosomale myotubul\u00e4re Myopathie, XL-MTM (MTM1, Labrador Retriever
Variante)<\/div>\n

[\/et_pb_text] [dmg_masonry_gallery _builder_version = \u201d4.18.0 '' _title = "in_title" hover_overlay_effect=\u201coverlay_image_data\u201c overlay_title_size=\u201c19px\u201c overlay_title_color=\u201c#FFFFFF\u201c show_overlay_caption=\u201coff\u201c overlay_caption_size=\u201c14px\u201c pagination_buttons_background=\u201cRGBA(255,255,255,0)\u201c pagination_buttons_background_active=\u201c#bcb8 40 \u2033 columns_tablet=\u201c2\u2033 columns_phone=\u201c2 \u2033 columns_last_edited=\u201con|desktop\u201c _builder_version=\u201c4.18.0\u201c _module_preset=\u201cdefault\u201c pagination_text_color=\u201c#bcb840\u201c pagination_font_size=\u201c12px\u201c pagination_active_text_color=\u201c#71615b\u201c pagination_active_font_size=\u201c12px\u201c hover_en able d=\u201c0\u2033 border_radii_image=\u201con |12px |12px|12px|12px\u201c border_radii_pagination=\u201con|6px|6px|6px|6px\u201c border_radii_pagination_active=\u201con|6px|6px|6px|6px\u201c box_shadow_style_pagination=\u201cpreset1\u2033 global_colors_info=\u201c{}\u201c theme_builder_area=\u201cpost_content \u201esticky_enabled =\u201c0\u2033][\/dmg_masonry_gallery][et_pb_text _builder_version=\u201c4.18.0\u201c _module_preset=\u201cdefault\u201c text_font=\u201c|300|||||||\u201c header_font=\u201c|300|||||||\u201c global_colors_info=\u201c{}\u201c]<\/p>\n

Der Rest:<\/strong><\/div>\n
<\/div>\n
MDR1-Arzneimittelsensitivit\u00e4t (ABCB1)<\/div>\n
P2Y12-Rezeptor-Thrombozyten-St\u00f6rung (P2Y12)<\/div>\n
Faktor-IX-Mangel,<\/div>\n
H\u00e4mophilie B (F9 Exon 7, Terrier-Variante) Faktor IX-Mangel,<\/div>\n
H\u00e4mophilie B (F9 Exon 7, Rhodesian Ridgeback-Variante) Faktor VII-Mangel (F7 Exon 5) Faktor VIII-Mangel,<\/div>\n
H\u00e4mophilie A (F8 Exon 10, Boxer-Variante) Faktor VIII-Mangel,<\/div>\n
H\u00e4mophilie A (F8 Exon 11, Deutscher Sch\u00e4ferhund Variante 1) Faktor VIII-Mangel, H\u00e4mophilie A (F8 Exon 1, Deutscher Sch\u00e4ferhund Variante 2)<\/div>\n
Thrombopathie (RASGRP1 Exon 5, Basset Hound-Variante)<\/div>\n
Thrombopathie (RASGRP1 Exon 8, Landseer-Variante)<\/div>\n
Thrombopathie (RASGRP1 Exon 5, Variante des amerikanischen Eskimohundes)<\/div>\n
Von-Willebrand-Krankheit Typ III, Typ III vWD (VWF Exon 4, Terrier-Variante)<\/div>\n
Von-Willebrand-Krankheit Typ III, Typ III vWD (VWF Exon 7, Shetland Sheepdog-Variante)<\/div>\n
Von-Willebrand-Krankheit Typ II, Typ II vWD (VWF, Pointer-Variante)<\/div>\n
Hunde-Leukozytenadh\u00e4sionsdefizit Typ I,<\/div>\n
CLAD I (ITGB2, Setter-Variante) Hunde-Leukozytenadh\u00e4sionsdefizit Typ III,<\/div>\n
CLAD III (FERMT3, Variante Deutscher Sch\u00e4ferhund)<\/div>\n
Angeborene Makrothrombozytopenie (TUBB1 Exon 1, Cairn- und Norfolk-Terrier-Variante)<\/div>\n
Glanzmann-Thrombasthenie Typ I (ITGA2B Exon 13, Variante der Gro\u00dfen Pyren\u00e4en)<\/div>\n
Glanzmann-Thrombasthenie Typ I (ITGA2B Exon 12, Otterhound-Variante)<\/div>\n
May-Hegglin-Anomalien (MYH9)<\/div>\n
Zus\u00e4tzliche getestete Bedingungen: Pr\u00e4kallikrein-Mangel (KLKB1 Exon 8)<\/div>\n
Pyruvatkinase-Mangel (PKLR Exon 5, Basenji-Variante)<\/div>\n
Pyruvatkinase-Mangel (PKLR Exon 7, Mops-Variante)<\/div>\n
Pyruvatkinase-Mangel (PKLR Exon 7, Beagle-Variante)<\/div>\n
Pyruvatkinase-Mangel (PKLR Exon 10, Terrier-Variante)<\/div>\n
Trapped-Neutrophil-Syndrom,<\/div>\n
TNS (VPS13B) Ligne\u00f6se Membranitis,<\/div>\n
LM (PLG) Thrombozytenfaktor-X-Rezeptor-Mangel,<\/div>\n
Scott-Syndrom (TMEM16F)<\/div>\n
Meth\u00e4moglobin\u00e4mie (CYB5R3)<\/div>\n
Angeborene Hypothyreose (TPO, Tenterfield-Terrier-Variante)<\/div>\n
Angeborene Hypothyreose (TPO, Ratte, Toy, Hairless Terrier-Variante)<\/div>\n
Komplement-3-Mangel,<\/div>\n
C3-Mangel (C3) Schwerer kombinierter Immundefekt,<\/div>\n
SCID (PRKDC, Terrier-Variante) Schwerer kombinierter Immundefekt,<\/div>\n
SCID (RAG1, Wetterhoun-Variante) X-chromosomaler schwerer kombinierter Immundefekt,<\/div>\n
X-SCID (IL2RG Exon 1, Basset Hound-Variante)<\/div>\n
X-chromosomaler schwerer kombinierter Immundefekt,<\/div>\n
X-SCID (IL2RG, Corgi-Variante)<\/div>\n
Progressive Netzhautatrophie, rcd1 (PDE6B Exon 21, Irish-Setter-Variante)<\/div>\n
Progressive Netzhautatrophie, rcd3 (PDE6A)<\/div>\n
Progressive Netzhautatrophie, CNGA (CNGA1 Exon 9)<\/div>\n
Progressive Netzhautatrophie, PRA1 (CNGB1)<\/div>\n
Zus\u00e4tzliche getestete Bedingungen Progressive Netzhautatrophie (SAG)<\/div>\n
Golden Retriever Progressive Netzhautatrophie 1,<\/div>\n
GR-PRA1 (SLC4A3) Progressive Netzhautatrophie,<\/div>\n
crd1 (PDE6B, American Staffordshire Terrier-Variante)<\/div>\n
X-chromosomale progressive Netzhautatrophie 1,<\/div>\n
XL-PRA1 (RPGR) Progressive Netzhautatrophie,<\/div>\n
PRA3 (FAM161A) Collie-Augenanomalien,<\/div>\n
Aderhauthypoplasie,<\/div>\n
CEA (NHEJ1) Tagesblindheit,<\/div>\n
Kegeldegeneration,<\/div>\n
Achromatopsie (CNGB3 Exon 6, Variante des Deutschen Kurzhaarzeigers)<\/div>\n
Achromatopsie (CNGA3 Exon 7, Variante Deutscher Sch\u00e4ferhund)<\/div>\n
Autosomal-dominante progressive Netzhautatrophie (RHO)<\/div>\n
Multifokale Retinopathie beim Hund, cmr1 (BEST1 Exon 2)<\/div>\n
Multifokale Retinopathie beim Hund, cmr2 (BEST1 Exon 5, Variante Coton de Tulear)<\/div>\n
Multifokale Retinopathie beim Hund, cmr3 (BEST1 Exon 10-Deletion,<\/div>\n
Finnischer und schwedischer Lapphund, lapponische Herder-Variante)<\/div>\n
Glaukom prim\u00e4rer offener Winkel (ADAMTS10 Exon 9, norwegische Elchhund-Variante)<\/div>\n
Glaukom prim\u00e4rer offener Winkel (ADAMTS10 Exon 17, Beagle-Variante)<\/div>\n
Glaukom prim\u00e4rer offener Winkel (ADAMTS17 Exon 11, Variante Basset Fauve de Bretagne)<\/div>\n
Prim\u00e4res Offenwinkelglaukom und prim\u00e4re Linsenluxation (ADAMTS17 Exon 2, chinesische Shar-Pei-Variante)<\/div>\n
Goniodysgenese und Glaukom,<\/div>\n
Dysplasie des pektin\u00e4ren Bandes,<\/div>\n
PLD (OLFM3) Erblicher Katarakt,<\/div>\n
Fr\u00fchauftretender Katarakt,<\/div>\n
Juvenile Katarakte (HSF4 Exon 9, Australian Shepherd-Variante)<\/div>\n
Prim\u00e4re Linsenluxation (ADAMTS17)<\/div>\n
Angeborene station\u00e4re Nachtblindheit (RPE65, Briard-Variante)<\/div>\n
Zus\u00e4tzliche getestete Bedingungen: Angeborene station\u00e4re Nachtblindheit (LRIT3, Beagle-Variante)<\/div>\n
2,8-Dihydroxyadenin-Urolithiasis,<\/div>\n
2,8-DHA Urolithiasis (APRT) Cystinurie Typ IA (SLC3A1, Neufundland-Variante)<\/div>\n
Cystinurie Typ II-A (SLC3A1, Australian Cattle Dog-Variante)<\/div>\n
Cystinurie Typ II-B (SLC7A9, Zwergpinscher-Variante)<\/div>\n
Polyzystische Nierenerkrankung,<\/div>\n
PKD (PKD1) Prim\u00e4re Hyperoxalurie<\/div>\n
(AGXT) Proteinverlustnephropathie,<\/div>\n
PLN (NPHS1) X-chromosomale heredit\u00e4re Nephropathie,<\/div>\n
XLHN (COL4A5 Exon 35, Samojede Variante 2)<\/div>\n
Autosomal rezessive heredit\u00e4re Nephropathie,<\/div>\n
famili\u00e4re Nephropathie,<\/div>\n
ARHN (COL4A4 Exon 3, Cocker Spaniel-Variante)<\/div>\n
Prim\u00e4re Ziliardyskinesie, PCD (CCDC39 Exon 3, Old English Sheepdog-Variante)<\/div>\n
Prim\u00e4re Ziliardyskinesie, PCD (NME5, Alaskan Malamute-Variante)<\/div>\n
X-chromosomale ektodermale Dysplasie,<\/div>\n
Anhidrotische ektodermale Dysplasie,<\/div>\n
XHED (EDA Intron 8) Nierenzystadenokarzinom und nodul\u00e4re Dermatofibrose,<\/div>\n
RCND (FLCN Exon 7)<\/div>\n
Hunde-Fukosidose (FUCA1), Glykogenspeicherkrankheit Typ II,<\/div>\n
Morbus Pompe,<\/div>\n
GSD II (GAA, finnischer und schwedischer Lapphund, lapponische Herder-Variante)<\/div>\n
Glykogenspeicherkrankheit Typ IA,<\/div>\n
Von-Gierke-Krankheit,<\/div>\n
GSD IA (G6PC, maltesische Variante)<\/div>\n
Glykogenspeicherkrankheit Typ IIIA,<\/div>\n
GSD IIIA (AGL, Curly Coated Retriever-Variante)<\/div>\n
Mukopolysaccharidose Typ IIIA,<\/div>\n
Sanfilippo-Syndrom Typ A,<\/div>\n
MPS IIIA (SGSH Exon 6, Dachshund-Variante) Mukopolysaccharidose Typ IIIA,<\/div>\n
Sanfilippo-Syndrom Typ A,<\/div>\n
MPS IIIA (SGSH Exon 6, neuseel\u00e4ndische Huntaway-Variante)<\/div>\n
Zus\u00e4tzliche getestete Bedingungen: Mukopolysaccharidose Typ VII,<\/div>\n
Sly-Syndrom,<\/div>\n
MPS VII (GUSB Exon 5, Terrier Brasileiro-Variante)<\/div>\n
Mukopolysaccharidose Typ VII,<\/div>\n
Sly-Syndrom,<\/div>\n
MPS VII (GUSB Exon 3, Variante Deutscher Sch\u00e4ferhund)<\/div>\n
Glykogenspeicherkrankheit Typ VII,<\/div>\n
Phosphofructokinase-Mangel,<\/div>\n
PFK-Mangel (PFKM, Whippet- und English Springer Spaniel-Variante)<\/div>\n
Glykogenspeicherkrankheit Typ VII,<\/div>\n
Phosphofructokinase-Mangel,<\/div>\n
PFK-Mangel (PFKM, Wachtelhund-Variante)<\/div>\n
Lagotto-Speicherkrankheit (ATG4D)<\/div>\n
Neuronale Ceroid-Lipofuszinose 1, NCL 1 (PPT1 Exon 8, Dachshund-Variante 1)<\/div>\n
Neuronale Ceroid-Lipofuszinose 2, NCL 2 (TPP1 Exon 4, Dachshund-Variante 2)<\/div>\n
Neuronale Ceroid-Lipofuszinose,<\/div>\n
Kleinhirnataxie, NCL4A (ARSG Exon 2, Variante American Staffordshire Terrier)<\/div>\n
Neuronale Ceroid-Lipofuszinose 5, NCL 5 (CLN5 Exon 4 SNP, Border-Collie-Variante)<\/div>\n
Neuronale Ceroid-Lipofuszinose 6, NCL 6 (CLN6 Exon 7, Australian Shepherd-Variante)<\/div>\n
Neuronale Ceroid-Lipofuszinose 8, NCL 8 (CLN8 Exon 2, englische Setter-Variante)<\/div>\n
Neuronale Ceroid-Lipofuszinose 7, NCL 7 (MFSD8, Chihuahua- und Chinese Crested-Variante)<\/div>\n
Neuronale Ceroid-Lipofuszinose 8, NCL 8 (CLN8, Australian Shepherd-Variante)<\/div>\n
Neuronale Ceroid-Lipofuszinose 10, NCL 10 (CTSD Exon 5, American-Bulldog-Variante)<\/div>\n
Neuronale Ceroid-Lipofuszinose 5, NCL 5 (CLN5-Exon-4-Deletion, Golden-Retriever-Variante)<\/div>\n
Neuronale Ceroid-Lipofuszinose mit Beginn im Erwachsenenalter, NCL A, NCL 12 (ATP13A2, Tibet-Terrier-Variante)<\/div>\n
Sp\u00e4t einsetzende neuronale Ceroid-Lipofuszinose, NCL 12 (ATP13A2, Australian Cattle Dog-Variante)<\/div>\n
GM1-Gangliosidose (GLB1-Exon 15, Shiba-Inu-Variante)<\/div>\n
GM1-Gangliosidose (GLB1-Exon 15, Alaskan-Husky-Variante)<\/div>\n
GM1-Gangliosidose (GLB1 Exon 2, Variante des portugiesischen Wasserhundes) Zus\u00e4tzliche getestete Bedingungen<\/div>\n
GM2-Gangliosidose (HEXA, japanische Chin-Variante)<\/div>\n
Globoidzell-Leukodystrophie,<\/div>\n
Krabbe-Krankheit (GALC Exon 5, Terrier-Variante)<\/div>\n
Autosomal-rezessive Amelogenesis Imperfecta,<\/div>\n
Famili\u00e4re Schmelzhypoplasie (ENAM-Deletion, italienische Greyhound-Variante)<\/div>\n
Autosomal-rezessive Amelogenesis Imperfecta,<\/div>\n
Famili\u00e4re Schmelzhypoplasie (ENAM SNP, Parson-Russell-Terrier-Variante)<\/div>\n
Anhaltendes M\u00fcller-Ductus-Syndrom,<\/div>\n
PMDS (AMHR2) Taubheit und Vestibularsyndrom des Dobermanns,<\/div>\n
DVDob, DINGS (MYO7A) Autoinflammatorische Shar-Pei-Krankheit,<\/div>\n
SPAID,<\/div>\n
Shar-Pei-Fieber (MTBP)<\/div>\n
Neonatale interstitielle Lungenerkrankung (LAMP3)<\/div>\n
Alaskan-Husky-Enzephalopathie,<\/div>\n
Subakute nekrotisierende Enzephalomyelopathie (SLC19A3)<\/div>\n
Kleinhirn-Abiotrophie,<\/div>\n
Neugeborene zerebell\u00e4re kortikale Degeneration,<\/div>\n
NCCD (SPTBN2, Beagle-Variante)<\/div>\n
Kleinhirnataxie,<\/div>\n
Progressive fr\u00fch einsetzende zerebell\u00e4re Ataxie (SEL1L, Variante des finnischen Laufhundes)<\/div>\n
Kleinhirnhypoplasie (VLDLR, Eurasier-Variante)<\/div>\n
Spinozerebell\u00e4re Ataxie,<\/div>\n
Sp\u00e4t einsetzende Ataxie,<\/div>\n
LoSCA (CAPN1)<\/div>\n
Spinozerebell\u00e4re Ataxie mit Myokymie und\/oder Krampfanf\u00e4llen (KCNJ10)<\/div>\n
Heredit\u00e4re Ataxie,<\/div>\n
Kleinhirndegeneration (RAB24, Old English Sheepdog- und Gordon-Setter-Variante)<\/div>\n
Gutartige famili\u00e4re jugendliche Epilepsie,<\/div>\n
Remittierende fokale Epilepsie (LGI2)<\/div>\n
Fetal beginnende neonatale neuroaxonale Dystrophie (MFN2, Riesenschnauzer-Variante)<\/div>\n
Hypomyelinisierung und Zittern (FNIP2, Weimaraner-Variante)<\/div>\n
Shaking-Puppy-Syndrom,<\/div>\n
X-chromosomales generalisiertes Tremor-Syndrom (PLP1, englische Springer-Spaniel-Variante)<\/div>\n
Neuroaxonale Dystrophie,<\/div>\n
NAD (TECPR2, spanische Wasserhundvariante)<\/div>\n
Zus\u00e4tzliche getestete Bedingungen Neuroaxonale Dystrophie,<\/div>\n
NAD (VPS11, Rottweiler-Variante)<\/div>\n
L-2-Hydroxyglutarazidurie,<\/div>\n
L2HGA (L2HGDH,<\/div>\n
Staffordshire-Bullterrier-Variante)<\/div>\n
Alaskan Malamute-Polyneuropathie,<\/div>\n
AMPN (NDRG1 SNP)<\/div>\n
Narkolepsie (HCRTR2 Exon 1, Dackelvariante)<\/div>\n
Progressive neuronale Abiotrophie,<\/div>\n
Degeneration des multiplen Systems beim Hund,<\/div>\n
CMSD (SERAC1 Exon 15, Kerry Blue Terrier-Variante)<\/div>\n
Progressive neuronale Abiotrophie,<\/div>\n
Degeneration des multiplen Systems beim Hund,<\/div>\n
CMSD (SERAC1 Exon 4, Chinese Crested-Variante)<\/div>\n
Juvenile Kehlkopfl\u00e4hmung und Polyneuropathie,<\/div>\n
Polyneuropathie mit Augenanomalien und neuronaler Vakuolisierung,<\/div>\n
POANV (RAB3GAP1, Rottweiler-Variante)<\/div>\n
Heredit\u00e4re sensorische autonome Neuropathie,<\/div>\n
Akrales Verst\u00fcmmelungssyndrom,<\/div>\n
AMS (GDNF-AS, Spaniel- und Pointer-Variante)<\/div>\n
Sensorische Neuropathie (FAM134B, Border-Collie-Variante)<\/div>\n
Juvenile Polyneuropathie,<\/div>\n
Leonberger Polyneuropathie 1,<\/div>\n
LPN1 (LPN1, ARHGEF10)<\/div>\n
Juvenile myoklonische Epilepsie (DIRAS1)<\/div>\n
Juvenile Polyneuropathie,<\/div>\n
Leonberger Polyneuropathie 2,<\/div>\n
LPN2 (GJA9) Schwammige Degeneration mit Kleinhirnataxie 1,<\/div>\n
SDCA1,<\/div>\n
SeSAME\/EAST-Syndrom (KCNJ10)<\/div>\n
Schwammige Degeneration mit Kleinhirnataxie 2,<\/div>\n
SDCA2 (ATP1B2) Dilatative Kardiomyopathie,<\/div>\n
DCM1 (PDK4, Dobermann Pinscher Variante 1)<\/div>\n
dilatative Kardiomyopathie,<\/div>\n
DCM2 (TTN, Dobermann Pinscher Variante 2)<\/div>\n
Long-QT-Syndrom (KCNQ1)<\/div>\n
Kardiomyopathie und Jugendsterblichkeit (YARS2)<\/div>\n
Muskeldystrophie (DMD, Golden-Retriever-Variante)<\/div>\n
Gliedma\u00dfeng\u00fcrtel-Muskeldystrophie (SGCD, Boston-Terrier-Variante)<\/div>\n
Zus\u00e4tzliche getestete Bedingungen: Vererbte Myopathie der Deutschen Dogge (BIN1)<\/div>\n
Myostatinmangel,<\/div>\n
Bully-Whippet-Syndrom (MSTN)<\/div>\n
Myotonia Congenita (CLCN1 Exon 7, Zwergschnauzer-Variante)<\/div>\n
Myotonia congenita (CLCN1 Exon 23, Australian Cattle Dog Variante)<\/div>\n
Entz\u00fcndliche Myopathie (SLC25A12) Hypokatalasie,<\/div>\n
Akatalas\u00e4mie (CAT)<\/div>\n
Pyruvat-Dehydrogenase-Mangel (PDP1, Spaniel-Variante)<\/div>\n
Maligne Hyperthermie (RYR1)<\/div>\n
Imerslund-Grasbeck-Syndrom,<\/div>\n
Selektive Cobalamin-Malabsorption (CUBN Exon 53, Border-Collie-Variante)<\/div>\n
Imerslund-Grasbeck-Syndrom,<\/div>\n
Selektive Cobalamin-Malabsorption (CUBN Exon 8, Beagle-Variante)<\/div>\n
Vererbte ausgew\u00e4hlte Cobalamin-Malabsorption mit Proteinurie (CUBN, Komondor-Variante)<\/div>\n
Lundehund-Syndrom (LEPREL1)<\/div>\n
Angeborenes Myasthenisches Syndrom,<\/div>\n
CMS (CHAT, altd\u00e4nische Vorstehhundvariante)<\/div>\n
Angeborenes Myasthenisches Syndrom,<\/div>\n
CMS (CHRNE, Jack-Russell-Terrier-Variante),<\/div>\n
CMS (COLQ, Golden Retriever-Variante)<\/div>\n
Myasthenia Gravis-\u00e4hnliches Syndrom (CHRNE, Heideterrier-Variante)<\/div>\n
Paroxysmale Dyskinesie,<\/div>\n
PxD (PIGN)<\/div>\n
Demyelinisierende Polyneuropathie (SBF2\/MTRM13)<\/div>\n
Dystrophische Epidermolysis bullosa (COL7A1, Golden Retriever-Variante)<\/div>\n
Dystrophische Epidermolysis bullosa (COL7A1, zentralasiatische Sch\u00e4ferhundvariante)<\/div>\n
Zus\u00e4tzliche getestete Bedingungen Ektodermale Dysplasie,<\/div>\n
Hautfragilit\u00e4tssyndrom (PKP1, Chesapeake Bay Retriever-Variante) Ichthyose,<\/div>\n
Epidermolytische Hyperkeratose (KRT10, Terrier-Variante)<\/div>\n
Ichthyose ICH1 (PNPLA1, Golden Retriever-Variante)<\/div>\n
Ichthyose (SLC27A4, Variante der Deutschen Dogge)<\/div>\n
Ichthyose (NIPAL4, American-Bulldog-Variante)<\/div>\n
Heredit\u00e4re Fu\u00dfballenhyperkeratose (FAM83G, Terrier- und Kromfohrlander-Variante)<\/div>\n
Heredit\u00e4re Fu\u00dfballenhyperkeratose (DSG1, Rottweiler-Variante)<\/div>\n
Musladin-Lueke-Syndrom,<\/div>\n
MLS (ADAMTSL2) Okulokutaner Albinismus,<\/div>\n
OCA (SLC45A2, Variante f\u00fcr kleine Rassen)<\/div>\n
Glatze-Oberschenkel-Syndrom (IGFBP5)<\/div>\n
t\u00f6dliche Akrodermatitis,<\/div>\n
LAD (MKLN1)<\/div>\n
Ehlers Danlos (ADAMTS2, Dobermann-Pinscher-Variante)<\/div>\n
Lippen- und\/oder Gaumenspalte (ADAMTS20, Variante Nova Scotia Duck Tolling Retriever)<\/div>\n
Heredit\u00e4re Vitamin-D-resistente Ricketts (VDR) Osteogenesis Imperfecta,<\/div>\n
\n
Glasknochenkrankheit (COL1A2, Beagle-Variante) Osteogenesis Imperfecta,<\/div>\n
Glasknochenkrankheit (SERPINH1, Dackelvariante)<\/div>\n
Osteogenesis imperfecta,<\/div>\n
Glasknochenkrankheit (COL1A1, Golden Retriever-Variante)<\/div>\n
Craniomandibul\u00e4re Osteopathie,<\/div>\n
CMO (SLC37A2) Raine-Syndrom,<\/div>\n
Zahnhypomineralisationssyndrom beim Hund (FAM20C)<\/div>\n
Chondrodystrophie (ITGA10,<\/div>\n
Norwegischer Elchhund und Karelischer B\u00e4renhund (Variante)<\/div>\n<\/div>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"

GesundheitstestsAustralian Labradoodle und Gesundheitstests. Hier sind die Krankheiten, auf die wir unsere Hunde testen: Die wichtigsten: \u2013 H\u00fcft- und Ellenbogendysplasie (FCI-Standards) \u2013 Falsches Fell \u2013 Von-Willebrand-Krankheit Typ I, Typ I vWD (VWF) \u2013 Elliptozytose des Hundes (SPTB Exon 30) \u2013 Pyruvatkinase-Mangel (PKLR) Exon 7, Labrador Retriever-Variante) \u2013 Progressive Netzhautatrophie, prcd (PRCD Exon [\u2026]<\/p>","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-5762","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/labradoodle.pl\/de\/wp-json\/wp\/v2\/pages\/5762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/labradoodle.pl\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/labradoodle.pl\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/labradoodle.pl\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/labradoodle.pl\/de\/wp-json\/wp\/v2\/comments?post=5762"}],"version-history":[{"count":6,"href":"https:\/\/labradoodle.pl\/de\/wp-json\/wp\/v2\/pages\/5762\/revisions"}],"predecessor-version":[{"id":5845,"href":"https:\/\/labradoodle.pl\/de\/wp-json\/wp\/v2\/pages\/5762\/revisions\/5845"}],"wp:attachment":[{"href":"https:\/\/labradoodle.pl\/de\/wp-json\/wp\/v2\/media?parent=5762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}